Stockreport

Reviva Pharmaceuticals to Participate in the Lytham Partners Fall 2024 Investor Conference

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF CUPERTINO, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical com [Read more]